TG Therapeutics Inc (TGTX)
34.50
+3.36
(+10.77%)
USD |
NASDAQ |
Nov 21, 16:00
34.60
+0.10
(+0.28%)
After-Hours: 20:00
TG Therapeutics Gross Profit Margin (Quarterly): 88.86% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 88.86% |
| June 30, 2024 | 88.70% |
| March 31, 2024 | 91.43% |
| December 31, 2023 | 82.14% |
| September 30, 2023 | 97.88% |
| June 30, 2023 | 88.11% |
| March 31, 2023 | 89.02% |
| December 31, 2022 | 96.25% |
| September 30, 2022 | 97.87% |
| June 30, 2022 | 96.13% |
| March 31, 2022 | 88.24% |
| December 31, 2021 | 90.95% |
| September 30, 2021 | 85.62% |
| June 30, 2021 | 90.42% |
| March 31, 2021 | 82.47% |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
82.14%
Minimum
Dec 2023
97.88%
Maximum
Sep 2023
90.27%
Average
89.02%
Median
Mar 2023
Gross Profit Margin (Quarterly) Benchmarks
| ADMA Biologics Inc | 49.78% |
| Varex Imaging Corp | 32.62% |
| Rhythm Pharmaceuticals Inc | 88.49% |
| Inspire Medical Systems Inc | 84.06% |
| Mirum Pharmaceuticals Inc | 76.98% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.40% |
| Return on Assets | -3.55% |
| Return on Invested Capital | -4.78% |
| Profit Margin (Quarterly) | 4.63% |
| Operating Margin (Quarterly) | 14.82% |
| Return on Net Operating Assets | -9.88% |